Quantifying value-based determinants of drug and non-drug decision dynamics

被引:8
|
作者
Smith, Aaron P. [1 ]
Beckmann, Joshua S. [2 ]
机构
[1] Univ Kansas, Cofrin Logan Ctr Addict Res & Treatment, Lawrence, KS 66045 USA
[2] Univ Kentucky, Dept Psychol, Lexington, KY 40506 USA
关键词
Reinforcement learning; Drug; Rat; Matching; Habit; Remifentanil; Opioid; Choice; GENERALIZED MATCHING LAW; CHOICE; REMIFENTANIL; ADDICTION; COCAINE; MODELS; FOOD; DEPRIVATION; DOPAMINE; BEHAVIOR;
D O I
10.1007/s00213-021-05830-x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale A growing body of research suggests that substance use disorder (SUD) may be characterized as disorders of decision making. However, drug choice studies assessing drug-associated decision making often lack more complex and dynamic conditions that better approximate contexts outside the laboratory and may lead to incomplete conclusions regarding the nature of drug-associated value. Objectives The current study assessed isomorphic (choice between identical food options) and allomorphic (choice between remifentanil [REMI] and food) choice across dynamically changing reward probabilities, magnitudes, and differentially reward-predictive stimuli in male rats to better understand determinants of drug value. Choice data were analyzed at aggregate and choice-by-choice levels using quantitative matching and reinforcement learning (RL) models, respectively. Results Reductions in reward probability or magnitude independently reduced preferences for food and REMI commodities. Inclusion of reward-predictive cues significantly increased preference for food and REMI rewards. Model comparisons revealed that reward-predictive stimuli significantly altered the economic substitutability of food and REMI rewards at both levels of analysis. Furthermore, model comparisons supported the reformulation of reward value updating in RL models from independent terms to a shared, relative term, more akin to matching models. Conclusions The results indicate that value-based quantitative choice models can accurately capture choice determinants within complex decision-making contexts and corroborate drug choice as a multidimensional valuation process. Collectively, the present study indicates commonalities in decision-making for drug and non-drug rewards, validates the use of economic-based SUD therapies (e.g., contingency management), and implicates the neurobehavioral processes underlying drug-associated decision-making as a potential avenue for future SUD treatment.
引用
收藏
页码:2047 / 2057
页数:11
相关论文
共 50 条
  • [41] Neurocognitive mechanisms underlying value-based decision-making: from core values to economic value
    Brosch, Tobias
    Sander, David
    FRONTIERS IN HUMAN NEUROSCIENCE, 2013, 7
  • [42] Body dynamics of gait affect value-based decisions
    Griessbach, Eric
    Incagli, Francesca
    Herbort, Oliver
    Canal-Bruland, Rouwen
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [43] Loss of Alternative Non-Drug Reinforcement Induces Relapse of Cocaine-Seeking in Rats: Role of Dopamine D1 Receptors
    Quick, Stacey L.
    Pyszczynski, Adam D.
    Colston, Kelli A.
    Shahan, Timothy A.
    NEUROPSYCHOPHARMACOLOGY, 2011, 36 (05) : 1015 - 1020
  • [44] An assessment of the use of drug and non-drug interventions in the treatment of Ichthyophthirius multifiliis Fouquet, 1876, a protozoan parasite of freshwater fish
    Picon-Camacho, S. M.
    Marcos-Lopez, M.
    Bron, J. E.
    Shinn, A. P.
    PARASITOLOGY, 2012, 139 (02) : 149 - 190
  • [45] Similar functional networks predict performance in both perceptual and value-based decision tasks
    Izakson, Liz
    Gal, Shachar
    Shahar, Moni
    Tavor, Ido
    Levy, Dino J.
    CEREBRAL CORTEX, 2023, 33 (06) : 2669 - 2681
  • [46] Goal congruency dominates reward value in accounting for behavioral and neural correlates of value-based decision-making
    Fromer, Romy
    Wolf, Carolyn K. Dean
    Shenhav, Amitai
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [47] Shared and divergent neural reactivity to non-drug operant response outcomes in current smokers and ex-smokers
    Nestor, Liam J.
    McCabe, Ella
    Jones, Jennifer
    Clancy, Luke
    Garavan, Hugh
    BRAIN RESEARCH, 2018, 1680 : 54 - 61
  • [48] Non-Drug Costs Associated with Outpatient Infliximab Administration in Pediatric Inflammatory Bowel Disease
    Wu, May
    Sin, Aaron
    Nishioka, Fred
    Park, K. T.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (07) : 1514 - 1517
  • [49] Abnormal Attentional Bias of Non-Drug Reward in Abstinent Heroin Addicts: An ERP Study
    Hao, Yanrong
    Li, Yonghui
    Li, Jianxiu
    Peng, Hong
    Zhao, Qinglin
    Hu, Bin
    IEEE TRANSACTIONS ON AFFECTIVE COMPUTING, 2022, 13 (03) : 1664 - 1676
  • [50] Proactive Information Sampling in Value-Based Decision-Making: Deciding When and Where to Saccade
    Song, Mingyu
    Wang, Xingyu
    Zhang, Hang
    Li, Jian
    FRONTIERS IN HUMAN NEUROSCIENCE, 2019, 13